智雲健康:醫療AI每年為公司減少了無數醫療事故
智雲健康集團CFO徐黎黎女士在今日舉行的2024年格隆匯·企業ESG趨勢論壇上表示:智雲健康是一家醫療AI公司,公司做了兩個大模型:一個叫ClouD GPT,一個叫ClouD DTx,這兩個大模型並不是蹭熱點,而是我們實際需要的。公司去年有兩個億的線上問診,大家想象一下如果有百萬分之一的差錯,這都是不能容忍的。ClouD GPT是我們的醫療AI,在真人醫生在問診開處方的同時,它自己在另外平行跑算法,有紅黃綠燈的機制,綠色就直接過了,黃燈就提醒醫生,紅燈看置信區間,如果超過某個置信區間我們就駁回這張處方再交給上級醫生重新進行問診開方,這點每年為公司規避了潛在的醫療事故,真正做到了降本增效。從這個角度來講,一方面是我們對社會的責任感,另外一方面也是減少醫療事故,對我們來講是直接影響,這是我們看到的一個通過AI技術改變醫療服務的流程。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.